Product Program year 2025 Source: CMS Open Payments

Fetal Fibronectin Enzyme Immunoassay

Device Diagnostics

PDI 15420045505346

Open in the dashboard

General payments

$212,874

791 payments

Research payments

$164,869

2 payments

Through program year 2025, $212,874 in general payments and $164,869 in research payments were reported against Fetal Fibronectin Enzyme Immunoassay (Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $106,973 545
2024 General $72,689 63
2024 Research $82,435 1
2023 General $13,576 131
2022 General $19,636 52
2022 Research $82,435 1

Breakdown

Who paid General payments · program years 2022–2025
  1. Hologic, LLC $116,122 745 payments
  2. Gen-Probe, Inc. $66,227 31 payments
  3. Hologic Inc $28,911 8 payments
  4. Gen-Probe Sales & Service, Inc. $1,614 7 payments
Top recipients General payments · program year 2025
  1. Michael Ruma Maternal & Fetal Medicine · Albuquerque, NM $66,923 63% · 33 payments
  2. Jessica McNeil Advanced Practice Midwife · Carrollton, TX $20,556 19% · 26 payments
  3. Tori Odaniel Obstetrics & Gynecology · Oklahoma City, OK $7,581 7% · 3 payments
  4. Rachael Sampson Maternal & Fetal Medicine · Pennington, NJ $505 <1% · 2 payments
  5. Ayda Garza Montalvo Obstetrics & Gynecology · Edinburg, TX $142 <1% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Maternal & Fetal Medicine Obstetrics & Gynecology $67,702 63% · 12 practitioners
  2. Advanced Practice Midwife $21,862 20% · 58 practitioners
  3. Obstetrics & Gynecology $14,418 14% · 267 practitioners
  4. Nurse Practitioner $482 <1% · 15 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $476 <1% · 21 practitioners

The top 5 of 22 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New Mexico $66,948 63% · 2 recipients
  2. Texas $22,528 21% · 56 recipients
  3. Oklahoma $7,581 7% · 1 recipient
  4. California $1,542 1% · 57 recipients
  5. North Carolina $1,221 1% · 59 recipients

The top 5 of 32 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

791 general · 2 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record